"Employer Health Plans and the Booming Weight Loss Drug Market: What You Need to Know"
TL;DR Summary
The multi-billion dollar weight loss drug market, including medications like Ozempic, Wegovy, and Moujaro, is causing a race to the pharmacy due to off-label use of diabetes medications for weight loss. The demand for these drugs has led to supply shortages, impacting both weight loss and diabetic patients. Medical professionals are urging patients to use only FDA-approved weight loss medications to ensure access for diabetic patients. However, supply chain issues and online scams are complicating the situation, with the market expected to exceed $100 billion by 2030.
- Multi-billion dollar weight loss drug market causes race to pharmacy FOX 59 Indianapolis
- Getting your hands on the new weight loss meds isn't simple WDSU New Orleans
- Most employer health plans don't cover new blockbuster weight loss drugs, but that's going to change CNBC
- Getting your hands on the new weight loss meds isn’t simple. Here are 5 things to know CNN
- Wegovy maker dinged employers for restricting hot weight-loss drugs Business Insider
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
4 min
vs 5 min read
Condensed
89%
808 → 87 words
Want the full story? Read the original article
Read on FOX 59 Indianapolis